ArticleBMC public health2025
Impact of abdominal obesity indices on all-cause and cardiovascular mortality in individuals with pre-diabetes and diabetes: insights from a prospective cohort study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lipid accumulation product and its association between new onset stroke among middle age and elderly population.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
aimsTo examine the relationships of abdominal obesity indices [visceral adiposity index (VAI), lipid accumulation product (LAP), and waist circumference (WC)] with all-cause and cardiovascular disease (CVD) mortality in varying glucose metabolism statuses populations.
methodsThis study utilized NHANES data (1999-2018), including 17,718 participants, and linked mortality documents from the National Death Index through December 31, 2019. Participants were categorized by glucose metabolism status into diabetes mellitus (DM), prediabetes (Pre-DM), or normal glucose regulation (NGR), and separately categorized as quartiles based on abdominal obesity indices. Cox proportional hazards regression models assessed the associations between glucose metabolism status, abdominal obesity indices, and all-cause and CVD mortality. The joint effect of glucose metabolism status and abdominal obesity was also analyzed. Restricted cubic splines (RCS) were applied to investigate potential non-linear relationships. The predictive performance of the models was evaluated using C-statistics to assess improvements with the inclusion of LAP or WC across different glucose metabolism statuses.
resultsAcross a median follow-up period of 9.4 years, 2,685 deaths (846 from CVD) were documented. Compared to NGR, Pre-DM and DM were associated with increased all-cause mortality [adjusted HR = 1.249 (1.132, 1.377) and 1.628 (1.429, 1.853)] and CVD mortality [HR = 1.321 (1.105, 1.579) and 1.665 (1.322, 2.097)]. As well as WC, were significant predictors of all-cause [HR = 1.527 (1.255, 1.859)] and CVD mortality [HR = 1.576 (1.104, 2.249)], while LAP was only associated with all-cause mortality [HR = 1.199 (1.029, 1.395)]. Combined analysis revealed that individuals with Pre-DM or DM in the highest quartiles of WC had 1.567-fold and 2.493-fold elevated risks of all-cause mortality, in contrast with individuals having NGR in the lowest quartiles. The inclusion of WC into the baseline models enhanced the C-statistics for assessing all-cause mortality in Pre-DM groups (p < 0.001).
conclusionsWC and LAP are important predictors of mortality, especially in those with impaired glucose metabolism. Integrating WC into predictive models enhances risk assessment for all-cause mortality in Pre-DM groups. These findings emphasize the importance of comprehensive risk assessments that incorporate both abdominal obesity and glucose metabolic health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.